We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
-9.54%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$455M
AUM Growth
-$72.3M
Cap. Flow
-$12.5M
Cap. Flow %
-2.74%
Top 10 Hldgs %
51.9%
Holding
94
New
10
Increased
20
Reduced
27
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 20.49%
2 Consumer Discretionary 19.55%
3 Financials 13.18%
4 Real Estate 9.6%
5 Technology 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VHAQ.RT
76
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$30K 0.01%
250,000
LFLY
77
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$24K 0.01%
+1,750
New +$97.4K
ARIZR
78
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$15K ﹤0.01%
250,000
SPKAR
79
DELISTED
SPK Acquisition Corp. Right
SPKAR
$6K ﹤0.01%
60,000
BCAB icon
80
BioAtla
BCAB
$5.46M
-1,307
Closed -$186K
KRON
81
DELISTED
Kronos Bio
KRON
-126,623
Closed -$461K
LQDA icon
82
Liquidia Corp
LQDA
$7.48B
-1,568,627
Closed -$6.84M
HTT
83
High Templar Tech Ltd
HTT
$379M
-690,290
Closed -$759K
RFL icon
84
Rafael Holdings
RFL
$101M
-304,200
Closed -$561K
RLJ.PRA icon
85
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$326M
-125,607
Closed -$3.26M
ECHO
86
EchoStar
ECHO
$24.4B
-7,862
Closed -$152K
OKUR
87
OnKure Therapeutics
OKUR
$154M
-2,098
Closed -$56K
TLIS
88
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
-18,982
Closed -$231K
DOMA
89
DELISTED
Doma Holdings, Inc.
DOMA
-12,000
Closed -$309K
AMYT
90
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
-29,656
Closed -$207K
EAR
91
DELISTED
Eargo, Inc. Common Stock
EAR
-65,603
Closed -$987K
RDUS
92
DELISTED
Radius Health, Inc.
RDUS
-381,998
Closed -$3.96M
EPZM
93
DELISTED
Epizyme, Inc
EPZM
-7,569,995
Closed -$11.1M

Similar funds

Newtyn Management's Q3 2022 Portfolio in Review

As of Q3 2022, Newtyn Management held 94 positions worth $455M, down 14% from $528M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Newtyn Management's Q3 2022 filing shows 10 new, 20 increased, 27 reduced and 14 closed positions. Its largest new stake was Sylvamo: 438,674 shares worth $14.9M. The largest sale was Epizyme, Inc, an estimated $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Newtyn Management's largest Q3 2022 buy was Sylvamo: 438,674 shares worth $14.9M.
  • Newtyn Management added most to People Inc in Q3 2022, an estimated $6.86M increase.
  • Newtyn Management's biggest Q3 2022 reduction was Algoma Steel, cutting an estimated $8.12M.
  • Newtyn Management fully exited Epizyme, Inc in Q3 2022, selling an estimated $11.1M.
  • Newtyn Management's ten largest holdings make up 52% of its $455M portfolio in Q3 2022.
  • Newtyn Management opened 10 new positions and closed 14 in Q3 2022.
  • Newtyn Management's portfolio value fell 14% quarter-over-quarter to $455M.

Based on Newtyn Management's 13F filing for Q3 2022, filed 14 Nov 2022.